SCHEMBL29212336

SCHEMBL29212336

CP(C)(=O)c1ccc(N)c2c1OC(F)(F)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29212393 0.75 EPAS1 (0.32) —
SCHEMBL25032477 0.71 LMNA (0.34) —
SCHEMBL29212490 0.71 — —
SCHEMBL25032072 0.70 IDO1 (0.33) —
SCHEMBL20355090 0.68 — —
SCHEMBL29560033 0.68 — —
SCHEMBL31270434 0.67 RXFP1 (0.35) —
SCHEMBL31304813 0.66 — —
SCHEMBL14007746 0.64 ADORA2A (0.44) —
SCHEMBL29975823 0.64 ADORA2A (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-12-05 — — US disclosed
EP-4384510-A1 COMPOUNDS TARGETING MUTANT OF P53 Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-06-19 — — EP disclosed
CN-117813295-A Compounds targeting p53 mutants 北京加科思新药研发有限公司 2024-04-02 — — CN disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed
Send feedback